Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3)
In part three of our series, I spoke with Ryan Confer, President and CEO of Genprex, about the company’s move from cancer into diabetes. The post Genprex bets on a one-time gene therapy for diabetes (Part 3 of 3) appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.
